Last reviewed: 28 Oct 2020
Last updated: 11 Aug 2020

Summary

Definition

History and exam

Key diagnostic factors

  • age <50 years
  • persistent cough
  • dry cough
  • long duration of symptoms

Other diagnostic factors

  • recent community exposure
  • throat involvement
  • fever
  • headache
  • diarrhea
  • bullous myringitis
  • lung rales/crepitations
  • rash

Risk factors

  • close community settings
  • immunosuppression
  • cigarette smoking
  • chronic lung disease
  • travel
  • male sex
  • immunomodulating drugs

Diagnostic investigations

1st investigations to order

  • chest x-ray
  • WBC count
  • hemoglobin
  • LFTs
  • oxygen saturation in air
  • BUN level
  • real-time reverse transcription polymerase chain reaction (RT-PCR) for SARS-CoV-2
More 1st investigations to order

Investigations to consider

  • urinary Legionella antigen
  • sputum culture for Legionella
  • molecular diagnosis of Mycoplasma pneumoniae or Chlamydophila pneumoniae
  • serology for atypical pathogens
  • nasopharyngeal viral cultures
More investigations to consider

Treatment algorithm

Contributors

Ran Nir-Paz

Associate Professor in Medicine

Department of Clinical Microbiology and Infectious Diseases

Hadassah Hebrew University Medical Center

Jerusalem

Israel

Disclosures

RNP has received research grants from US-Israel Binational Science Foundation, Hebrew University, Rosetrees Trust, and SpeeDx. He is chair of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Mycoplasma and Chlamydia Infections (ESGMAC). RNP is a consultant for and has stocks in eDAS Healthcare. 

Peer reviewersVIEW ALL

Honorary Senior Lecturer (University of Manchester)

Consultant in General & Respiratory Medicine

Department of Respiratory Medicine

Manchester Royal Infirmary

Manchester

UK

Disclosures

MW is an author of a reference cited in this topic.

H.E. Sellers Research Chair in Infectious Diseases

Head

Section of Adult Infectious Diseases

Department of Internal Medicine

Department of Medical Microbiology

University of Manitoba

Winnipeg

Canada

Disclosures

At the time of the peer review, Professor Rubinstein declared no competing interests. We were made aware that Professor Rubinstein is now deceased.

Use of this content is subject to our disclaimer